A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress

Ceconi, 2003, Oxidative stress in cardiovascular disease: myth or fact?, Arch Biochem Biophys, 420, 217, 10.1016/j.abb.2003.06.002

Sohal, 2002, Mechanisms of aging: an appraisal of the oxidative stress hypothesis, Free Radic Biol Med, 33, 575, 10.1016/S0891-5849(02)00886-9

Uchida, 2000, Role of reactive aldehyde in cardiovascular diseases, Free Radic Biol Med, 28, 1685, 10.1016/S0891-5849(00)00226-4

Pryor, 1975, A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation, J Org Chem, 40, 3615, 10.1021/jo00912a038

Frankel, 1983, Formation of malonaldehyde from lipid oxidation products, Biochim Biophys Acta, 754, 264, 10.1016/0005-2760(83)90141-8

Esterbauer, 1991, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, Free Radic Biol Med, 11, 81, 10.1016/0891-5849(91)90192-6

Hecker, 1989, On the mechanism of prostacyclin and thromboxane A2 biosynthesis, J Biol Chem, 264, 141, 10.1016/S0021-9258(17)31235-8

Marnett, 1999, Lipid peroxidation-DNA damage by malondialdehyde, Mutat Res, 424, 83, 10.1016/S0027-5107(99)00010-X

VanderVeen, 2003, Induction of frameshift and base pair substitution mutations by the major DNA adduct of the endogenous carcinogen malondialdehyde, Proc Natl Acad Sci U S A, 100, 14247, 10.1073/pnas.2332176100

Niedernhofer, 2003, Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells, J Biol Chem, 278, 31426, 10.1074/jbc.M212549200

Voitkun, 1999, Analysis of DNA-protein crosslinking activity of malondialdehyde in vitro, Mutat Res, 424, 97, 10.1016/S0027-5107(99)00011-1

Palinski, 1994, ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum, Arterioscler Thromb, 14, 605, 10.1161/01.ATV.14.4.605

Slatter, 2000, The importance of lipid-derived malondialdehyde in diabetes mellitus, Diabetologia, 43, 550, 10.1007/s001250051342

Knight, 1988, Specificity of the thiobarbituric acid reaction: its use in studies of lipid peroxidation, Clin Chem, 34, 2433, 10.1093/clinchem/34.12.2433

Yagi, 1976, A simple fluorometric assay for lipoperoxide in blood plasma, Biochem Med, 15, 212, 10.1016/0006-2944(76)90049-1

Templar, 1999, Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method, Nephrol Dial Transplant, 14, 946, 10.1093/ndt/14.4.946

Chirico, 1994, High-performance liquid chromatography-based thiobarbituric acid tests, Methods Enzymol, 233, 314, 10.1016/S0076-6879(94)33035-2

Agarwal, 2002, Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples, J Chromatogr B Analyt Technol Biomed Life Sci, 775, 121, 10.1016/S1570-0232(02)00273-8

Del Rio, 2003, Rapid fluorimetric method to detect total plasma malondialdehyde with mild derivatization conditions, Clin Chem, 49, 690, 10.1373/49.4.690

Espinosa-Mansilla, 1996, Kinetic behaviour of the malonaldehyde-thiobarbituric acid reaction. kinetic-fluorimetric determination of malonaldehyde in human serum, Anal Chim Acta, 320, 125, 10.1016/0003-2670(95)00530-7

Sheu, 2003, Determination of thiobarbituric acid adduct of malondialdehyde using on-line microdialysis coupled with high-performance liquid chromatography, Anal Sci, 19, 621, 10.2116/analsci.19.621

Karatas, 2002, Determination of free malondialdehyde in human serum by high-performance liquid chromatography, Anal Biochem, 311, 76, 10.1016/S0003-2697(02)00387-1

Wilson, 1997, Direct method for quantification of free malondialdehyde with high-performance capillary electrophoresis in biological samples, Clin Chem, 43, 1982, 10.1093/clinchem/43.10.1982

Sim, 2003, Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard, J Chromatogr B Analyt Technol Biomed Life Sci, 785, 337, 10.1016/S1570-0232(02)00956-X

Steghens, 2001, Diaminonaphthalene, a new highly specific reagent for HPLC-UV measurement of total and free malondialdehyde in human plasma or serum, Free Radic Biol Med, 31, 242, 10.1016/S0891-5849(01)00578-0

Cighetti, 1999, Free and total malondialdehyde assessment in biological matrices by gas chromatography-mass spectrometry: what is needed for an accurate detection, Anal Biochem, 266, 222, 10.1006/abio.1998.2952

Cighetti, 2002, Use of methyl malondialdehyde as an internal standard for malondialdehyde detection: validation by isotope-dilution gas chromatography-mass spectrometry, Clin Chem, 48, 2266, 10.1093/clinchem/48.12.2266

Stalikas, 2001, Analysis of malondialdehyde in biological matrices by capillary gas chromatography with electron-capture detection and mass spectrometry, Anal Biochem, 290, 108, 10.1006/abio.2000.4951

Suttnar, 2001, Influence of citrate and EDTA anticoagulants on plasma malondialdehyde concentrations estimated by high-performance liquid chromatography, J Chromatogr B Biomed Sci Appl, 751, 193, 10.1016/S0378-4347(00)00453-9

Larstad, 2002, Determination of malondialdehyde in breath condensate by high-performance liquid chromatography with fluorescence detection, J Chromatogr B Analyt Technol Biomed Life Sci, 766, 107, 10.1016/S0378-4347(01)00437-6

Korchazhkina, 2003, Measurement by reversed-phase high-performance liquid chromatography of malondialdehyde in normal human urine following derivatisation with 2,4-dinitrophenylhydrazine, J Chromatogr B Analyt Technol Biomed Life Sci, 794, 353, 10.1016/S1570-0232(03)00495-1

Doerge, 1998, Mass spectrometric analysis of 2-deoxyribonucleoside and 2′-deoxyribonucleotide adducts with aldehydes derived from lipid peroxidation, Rapid Commun Mass Spectrom, 12, 1665, 10.1002/(SICI)1097-0231(19981130)12:22<1665::AID-RCM384>3.0.CO;2-8

Otteneder, 2002, Reaction of malondialdehyde-DNA adducts with hydrazines-development of a facile assay for quantification of malondialdehyde equivalents in DNA, Chem Res Toxicol, 15, 312, 10.1021/tx010105v

Rouzer, 1997, Analysis of the malondialdehyde-2′-deoxyguanosine adduct pyrimidopurinone in human leukocyte DNA by gas chromatography/electron capture/negative chemical ionization/mass spectrometry, Chem Res Toxicol, 10, 181, 10.1021/tx9601216

Hakala, 1999, Mass spectrometric (HPLC/ESI–MS/MS) quantification of pyrimido[1,3-a]purin-10(3H)-one, a guanine adduct formed by reaction of malondialdehyde with DNA, J Pharm Biomed Anal, 21, 1053, 10.1016/S0731-7085(99)00228-9

Yi, 1998, An improved 32P-postlabeling/high-performance liquid chromatography method for the analysis of the malondialdehye-derived 1, N2-propanodeoxyguanosine DNA adduct in animal and human tissues, Chem Res Toxicol, 11, 1032, 10.1021/tx9800497

Leuratti, 1998, Determination of malondialdehyde-induced DNA damage in human tissues using an immunoslot blot assay, Carcinogenesis, 19, 1919, 10.1093/carcin/19.11.1919

Otteneder, 2003, Development of a method for determination of the malondialdehyde-deoxyguanosine adduct in urine using liquid chromatography-tandem mass spectrometry, Anal Biochem, 315, 147, 10.1016/S0003-2697(02)00697-8

Gonenc, 2001, Plasma malondialdehyde (MDA) levels in breast and lung cancer patients, J Clin Pharm Ther, 26, 141, 10.1046/j.1365-2710.2001.00334.x

Young, 1991, Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection, Ann Clin Biochem, 28, 504, 10.1177/000456329102800514

Akbulut, 2003, Daily variations of plasma malondialdehyde levels in patients with early breast cancer, Cancer Detect Prev, 27, 122, 10.1016/S0361-090X(03)00029-1

Gonca Akbulut, 1999, Differential effects of pharmacological doses of melatonin on malondialdehyde and glutathione levels in young and old rats, Gerontology, 45, 67, 10.1159/000022065

Kolanjiappan, 2002, Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients, Clin Chim Acta, 326, 143, 10.1016/S0009-8981(02)00300-5

Cynamon, 1985, Erythrocyte malondialdehyde release in vitro: a functional measure of vitamin E status, Clin Chim Acta, 151, 169, 10.1016/0009-8981(85)90320-1

Manju, 2002, Circulating lipid peroxidation and antioxidant status in cervical cancer patients: a case-control study, Clin Biochem, 35, 621, 10.1016/S0009-9120(02)00376-4

Bakan, 2002, Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer, Jpn J Clin Oncol, 32, 162, 10.1093/jjco/hyf035

Satoh, 1978, Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method, Clin Chim Acta, 90, 37, 10.1016/0009-8981(78)90081-5

Bakan, 2003, Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia, Clin Chim Acta, 338, 143, 10.1016/j.cccn.2003.08.013

Jain, 1989, Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes, Diabetes, 38, 1539, 10.2337/diabetes.38.12.1539

Yoneyama, 2002, Relationship between plasma malondialdehyde levels and adenosine deaminase activities in preeclampsia, Clin Chim Acta, 322, 169, 10.1016/S0009-8981(02)00175-4

Chirico, 1993, Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test, Free Radic Res Commun, 19, 51, 10.3109/10715769309056498

Orhan, 2001, Correlation between plasma malondialdehyde and ceruloplasmin activity values in preeclamptic pregnancies, Clin Biochem, 34, 505, 10.1016/S0009-9120(01)00238-7

Richard, 1991, Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure, Nephron, 57, 10, 10.1159/000186208

Ilhan, 2002, The changes of trace elements, malondialdehyde levels and superoxide dismutase activities in pregnancy with or without preeclampsia, Clin Biochem, 35, 393, 10.1016/S0009-9120(02)00336-3

Dierckx, 2003, Oxidative stress status in patients with diabetes mellitus: relationship to diet, Eur J Clin Nutr, 57, 999, 10.1038/sj.ejcn.1601635

Nielsen, 1997, Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors, Clin Chem, 43, 1209, 10.1093/clinchem/43.7.1209

Martin-Gallan, 2003, Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications, Free Radic Biol Med, 34, 1563, 10.1016/S0891-5849(03)00185-0

Wasowicz, 1993, Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage, Clin Chem, 39, 2522, 10.1093/clinchem/39.12.2522

Polidori, 2002, Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity, Free Radic Biol Med, 32, 148, 10.1016/S0891-5849(01)00782-1

Suttnar, 1997, Solid-phase extraction in malondialdehyde analysis, Anal Biochem, 249, 20, 10.1006/abio.1997.2157

Tamer, 2002, Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atherosclerotic patients, Arch Med Res, 33, 257, 10.1016/S0188-4409(01)00381-2

Boaz, 1999, Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis, Kidney Int, 56, 1078, 10.1046/j.1523-1755.1999.00613.x

Boaz, 1999, Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients, Am J Kidney Dis, 34, 438, 10.1016/S0272-6386(99)70070-3

Bird, 1984, Comparative studies on different methods of malonaldehyde determination, Methods Enzymol, 105, 299, 10.1016/S0076-6879(84)05038-2

Ozden, 2002, Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients, Clin Biochem, 35, 269, 10.1016/S0009-9120(02)00307-7

Yoshioka, 1979, Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood, Am J Obstet Gynecol, 135, 372, 10.1016/0002-9378(79)90708-7

Loguercio, 2003, Oxidative stress in viral and alcoholic hepatitis, Free Radic Biol Med, 34, 1, 10.1016/S0891-5849(02)01167-X

Delibas, 2002, Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval, Clin Biochem, 35, 137, 10.1016/S0009-9120(02)00287-4

Chi, 2002, Total antioxidant capacity and malondialdehyde in acute abdominal pain, Am J Emerg Med, 20, 79, 10.1053/ajem.2002.30102

Leuratti, 2002, Detection of malondialdehyde DNA adducts in human colorectal mucosa: relationship with diet and the presence of adenomas, Cancer Epidemiol Biomarkers Prev, 11, 267

Zhang, 2002, Immunohistochemical detection of malondialdehyde-DNA adducts in human oral mucosa cells, Carcinogenesis, 23, 207, 10.1093/carcin/23.1.207

Sander, 2003, Oxidative stress in malignant melanoma and non-melanoma skin cancer, Br J Dermatol, 148, 913, 10.1046/j.1365-2133.2003.05303.x